|
|
| MRD / Regn No. |
: SG004691 |
Date |
: 20/07/2026 |
| Patient Name |
: Atul Surana |
Age & Gender |
: 47 Yrs. / Male |
| Contact No. |
: 9874522022 |
UHID |
: |
| Ht / Wt / BMI |
: 178 / 107 / 33.77 |
BP S / BP D |
: 132 / 86 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
DYSLIPIDEMIA (20/Jul/2026) | HYPERTENSION (20/Jul/2026) | TYPE 2 DIABETES (20/Jul/2026) | |
| Salient Investigations |
: |
TGL TRIGLYCERIDE: 159 mg/dL | CREATININE: 0.91 | FASTING PLASMA GLUCOSE (FPG): 136 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 6.7 % | LDL LOW DENSITY LIPOPROTEIN: 91 mg/dL | MICROALBUMIN CREATININE RATIO: 22.98 mcg/mg | POST PRANDIAL GLUCOSE (2HPP): 159 mg/dL | TSH THYROID STIMULATING HORMONE: 6.41 mIU/L | TGL TRIGLYCERIDE: 159 mg/dL | CREATININE: 0.91 | EGFR EGLOMERULAR FILTRATION RATE: 95.14 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 136 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 6.7 % | LDL LOW DENSITY LIPOPROTEIN: 91 mg/dL | MICROALBUMIN CREATININE RATIO: 22.98 mcg/mg | POST PRANDIAL GLUCOSE (2HPP): 159 mg/dL | TSH THYROID STIMULATING HORMONE: 6.41 mIU/L |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET TELMISARTAN 40 MG + ATORVASTATIN 10 MG
ARBITEL AV
Medicine For PO |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
2 |
ANTIHYPERGLYCEMIC TIRZEPATIDE 2.5 MG
MOUNJARO 2.5 MG |
SC |
1-0-0 |
ONCE A WEEK
|
4 WEEKS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 20/Aug/2026 |
| Tests Suggested For Next Visit |
: FPG |
| |
|
| |
|
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal /
54020
This is a Computer generated Prescription |
Powered By:  |